1. Home
  2. VKTX vs ALE Comparison

VKTX vs ALE Comparison

Compare VKTX & ALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • ALE
  • Stock Information
  • Founded
  • VKTX 2012
  • ALE 1906
  • Country
  • VKTX United States
  • ALE United States
  • Employees
  • VKTX N/A
  • ALE N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • ALE Power Generation
  • Sector
  • VKTX Health Care
  • ALE Utilities
  • Exchange
  • VKTX Nasdaq
  • ALE Nasdaq
  • Market Cap
  • VKTX 3.8B
  • ALE 3.8B
  • IPO Year
  • VKTX 2015
  • ALE N/A
  • Fundamental
  • Price
  • VKTX $34.40
  • ALE $67.53
  • Analyst Decision
  • VKTX Strong Buy
  • ALE
  • Analyst Count
  • VKTX 14
  • ALE 0
  • Target Price
  • VKTX $87.07
  • ALE N/A
  • AVG Volume (30 Days)
  • VKTX 4.3M
  • ALE 606.6K
  • Earning Date
  • VKTX 10-22-2025
  • ALE 10-31-2025
  • Dividend Yield
  • VKTX N/A
  • ALE 4.32%
  • EPS Growth
  • VKTX N/A
  • ALE N/A
  • EPS
  • VKTX N/A
  • ALE 2.85
  • Revenue
  • VKTX N/A
  • ALE $1,500,300,000.00
  • Revenue This Year
  • VKTX N/A
  • ALE $2.24
  • Revenue Next Year
  • VKTX N/A
  • ALE $5.63
  • P/E Ratio
  • VKTX N/A
  • ALE $23.72
  • Revenue Growth
  • VKTX N/A
  • ALE N/A
  • 52 Week Low
  • VKTX $18.92
  • ALE $62.38
  • 52 Week High
  • VKTX $56.25
  • ALE $67.60
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 44.88
  • ALE 64.16
  • Support Level
  • VKTX $34.67
  • ALE $67.35
  • Resistance Level
  • VKTX $43.15
  • ALE $67.57
  • Average True Range (ATR)
  • VKTX 2.70
  • ALE 0.12
  • MACD
  • VKTX -0.69
  • ALE -0.05
  • Stochastic Oscillator
  • VKTX 13.85
  • ALE 75.44

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About ALE Allete Inc.

ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.

Share on Social Networks: